ALTx Therapeutics
PrivateLast Round
Accelerator
Feb 5, 2026
Total Funding Raised
$17.05M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
ALTx Therapeutics is a drug discovery company that develops precision cancer therapies targeting the Alternative Lengthening of Telomeres (ALT) pathway.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ALTx Therapeutics Comparables
Compare ALTx Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tessellate BIO | 89% | |
| Artios Pharma | 72% | |
| FoRx Therapeutics | 71% |
ALTx Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Feb 5, 2026 |
ALTx Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Syncona | Accelerator |
| The Francis Crick Institute | Accelerator |
| Cancer Research Horizons | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 5, 2026
$17M raised with participation from Syncona and Cancer Research Horizons.
ALTx Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about ALTx Therapeutics's valuation, stock price, and market status.
Is ALTx Therapeutics a public or private company?
ALTx Therapeutics is a private company.
What is the current stock price of ALTx Therapeutics?
ALTx Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is ALTx Therapeutics worth (valuation)?
Valuation information for ALTx Therapeutics is not publicly available.
Can I buy ALTx Therapeutics stock?
ALTx Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was ALTx Therapeutics's last funding round?
ALTx Therapeutics's most recent funding round was Accelerator on February 5, 2026.
Who are the main investors in ALTx Therapeutics?
Key investors in ALTx Therapeutics include Syncona, The Francis Crick Institute, Cancer Research Horizons.
Will ALTx Therapeutics IPO soon?
No public IPO plans have been announced for ALTx Therapeutics.
How can I track ALTx Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor ALTx Therapeutics's secondary market activity and sign up for updates.